U.s. Army Medical Research And Development Command

This early-stage study tests whether a new vaccination schedule for an experimental HIV vaccine is safe and triggers an immune response. Healthy adults aged 18-50 will receive either the vaccine or a placebo. The goal is to find a better way to protect against HIV.